Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gore

Showing results (751-760 of 833) with videos related to

Pageof 84
Sort By:
Circulation|March 14, 1998
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-IK W Mahaffey, C B Granger, M A Sloan, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2016
The discovery of quinoline based single-ligand human H<sub>1</sub> and H<sub>3</sub> receptor antagonistsPanayiotis A Procopiou, Rachael A Ancliff, Paul M Gore, et al.
European Heart Journal|March 17, 2010
Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspectiveFrederick A Spencer, Gilles Montalescot, Keith A A Fox, et al.
The American Journal of Cardiology|July 17, 2007
Differences between local hospital and core laboratory interpretation of the admission electrocardiogram in patients with acute coronary syndromes and their relation to outcomeRaymond T Yan, Andrew T Yan, Jeanna Allegrone, et al.
American Heart Journal|September 1, 1999
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary ArteriesK W Mahaffey, C B Granger, M A Sloan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II studyG J Creemers, G Bolis, M Gore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2011
A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancerG Rustin, N Reed, G C Jayson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancerW ten Bokkel Huinink, M Gore, J Carmichael, et al.
American Heart Journal|March 1, 2006
The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE)Shaun G Goodman, Philippe Gabriel Steg, Kim A Eagle, et al.
Physics and Imaging in Radiation Oncology|November 30, 2023
Development of a comprehensive cardiac atlas on a 1.5 Tesla Magnetic Resonance Linear AcceleratorAronne M Schottstaedt, Eric S Paulson, Jason C Rubenstein, et al.
Pageof 84

Showing results (751-760 of 833) with videos related to

Sort By:
Pageof 84
Circulation|March 14, 1998
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-IK W Mahaffey, C B Granger, M A Sloan, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2016
The discovery of quinoline based single-ligand human H<sub>1</sub> and H<sub>3</sub> receptor antagonistsPanayiotis A Procopiou, Rachael A Ancliff, Paul M Gore, et al.
European Heart Journal|March 17, 2010
Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspectiveFrederick A Spencer, Gilles Montalescot, Keith A A Fox, et al.
The American Journal of Cardiology|July 17, 2007
Differences between local hospital and core laboratory interpretation of the admission electrocardiogram in patients with acute coronary syndromes and their relation to outcomeRaymond T Yan, Andrew T Yan, Jeanna Allegrone, et al.
American Heart Journal|September 1, 1999
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary ArteriesK W Mahaffey, C B Granger, M A Sloan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II studyG J Creemers, G Bolis, M Gore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2011
A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancerG Rustin, N Reed, G C Jayson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancerW ten Bokkel Huinink, M Gore, J Carmichael, et al.
American Heart Journal|March 1, 2006
The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE)Shaun G Goodman, Philippe Gabriel Steg, Kim A Eagle, et al.
Physics and Imaging in Radiation Oncology|November 30, 2023
Development of a comprehensive cardiac atlas on a 1.5 Tesla Magnetic Resonance Linear AcceleratorAronne M Schottstaedt, Eric S Paulson, Jason C Rubenstein, et al.
Pageof 84